એરિસ્ટો બાયો-ટેક અને લાઇફસાયન્સ શેર કિંમત

એરિસ્ટો બાયો-ટેક અને લાઇફસાયન્સ ઇન્વેસ્ટમેન્ટ રેટિંગ

• માસ્ટર રેટિંગ:

• Aristo Bio-Tech And Lifescience has an operating revenue of Rs. 796.21 Cr. on a trailing 12-month basis. An annual revenue growth of 12% is good, Pre-tax margin of 2% needs improvement, ROE of 11% is good. The company has a reasonable debt to equity of 30%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 35% and 73% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 37% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 90 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 38 indicates it belongs to a strong industry group of Chemicals-Agricultural and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

  ડિસ્ક્લેમર: આ સ્ટૉક એનાલિસિસ રિપોર્ટ માત્ર માહિતીના હેતુઓ માટે અલ્ગોરિધમ રૂપે બનાવવામાં આવે છે અને તેને ખરીદ અથવા વેચાણની ભલામણ તરીકે ગણવામાં આવશે નહીં.